Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Candidate Biomarkers in CSF1R-Related Disorder
Xavier Ayrignac, Cecilia Marelli, Sylvain Lehmann, Camille Huiban, Hemmo A.F. Yska, Pierre Labauge, Isabelle Le Ber, Fanny Mochel · 2026
Read Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Candidate Biomarkers in CSF1R-Related Disorder by Xavier Ayrignac, Cecilia Marelli, Sylvain Lehmann, Camille Huiban, Hemmo A.F. Yska, Pierre Labauge, Isabelle Le Ber, Fanny Mochel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13262667.txt.
Description
Xavier Ayrignac and colleagues test two blood proteins as trackers for a rare inherited brain disease. CSF1R-related disorder destroys white matter in adults and is often mistaken for other conditions. Stem cell transplants can help, so measuring progression matters. Their 2026 study compares twenty-two patients against several look-alike diseases.
Both neurofilament light chain, a nerve damage marker, and the glial protein GFAP ran high in these patients. GFAP stood even higher than in a genetic frontotemporal dementia group after age adjustment. Within the disease group, both markers rose with disability scores. GFAP also tracked thinking speed and anxiety, strengthening its candidacy for monitoring trials.
Catalog record
| CREATOR | Xavier Ayrignac, Cecilia Marelli, Sylvain Lehmann, Camille Huiban, Hemmo A.F. Yska, Pierre Labauge, Isabelle Le Ber, Fanny Mochel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 12 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |